NIRSense is a company founded in 2018 with a focus on developing advanced cerebral oximetry devices for the U.S. military to monitor and prevent hemorrhage-related deaths and cognitive impairment in high-altitude and high-g-force conditions. They have received a grant from the Defense Innovation Unit to create devices that deliver accurate tissue oxygenation data in extreme environments. NIRSense also works on developing oximetry monitors for various military applications and adapting their technology, Total OximetryTM, for civilian healthcare. The company operates in Richmond, VA and Cary, NC, with a team of experts in business management, startups, process management, patent management, and engineering.